Time, action and psychosis: Using subjective time to investigate the effects of ketamine on sense of agency

Neuropsychologia

Volumn 51, Issue 2, 2013, Pages 377-384

  Moore, J W ^a,b   Cambridge, V C ^a   Morgan, H ^a   Giorlando, F ^c   Adapa, R ^d   Fletcher, P C ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Action; Consciousness; Ketamine; Prodromal; Prodrome; Schizophrenia; Sense of agency; Time; Volition

Indexed keywords

KETAMINE; PLACEBO;

ADULT; ARTICLE; BODY PERCEPTION; CLINICAL ARTICLE; CLINICIAN ADMINISTERED DISSOCIATIVE STATES SCALE; CONTROLLED STUDY; DATA ANALYSIS; DELUSION; DEPTH PERCEPTION; DISEASE MODEL; DRUG ACTIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECHALLENGE; DRUG TOXICITY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PSYCHOSIS; PSYCHOTOMIMETIC ACTIVITY; RESPONSE TIME; SCHIZOPHRENIA; TASK PERFORMANCE; TIME PERCEPTION;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INTENTION; JUDGMENT; KETAMINE; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SENSATION; YOUNG ADULT;

EID: 84872283293     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2012.07.005     Document Type: Article

References (51)

1. Blakemore Sarah, Wolpert D., Frith C. Abnormalities in the awareness of action. Trends in Cognitive Sciences 2002, 6(6):237-242.
2. Blakemore S.J., Smith J., Steel R., Johnstone E., Frith C. The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring. Psychological Medicine 2000, 30(5):1131.
3. Bremner J.D., Krystal J.H., Putnam F.W., Southwick S.M., Marmar C., Charney D.S., Mazure C.M.). Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS). Journal of Traumatic Stress 1998, 11(1):125-136. 10.1023/A:1024465317902.
4. Buehner M.J., Humphreys G.R. Causal binding of actions to their effects. Psychological Science 2009, 20(10):1221.
5. Corlett P.R., Honey G.D., Fletcher P.C. From prediction error to psychosis: ketamine as a pharmacological model of delusions. Journal of Psychopharmacology (Oxford, England) 2007, 21(3):238-252. 10.1177/0269881107077716.
6. Corlett P.R, Honey G.D., Aitken M.R.F., Dickinson A., Shanks D.R., Absalom A.R., Lee M., et al. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Archives of General Psychiatry 2006, 63(6):611-621. 10.1001/archpsyc.63.6.611.
7. Corlett P.R, Honey G.D., Krystal J.H., Fletcher P.C. Glutamatergic model psychoses: prediction error, learning, and inference. Neuropsychopharmacology 2010, Retrieved from. 10.1038/npp.2010.163.
8. Corlett P.R., Frith C.D., Fletcher P.C. From drugs to deprivation: a Bayesian framework for understanding models of psychosis. Psychopharmacology 2009, 206(4):515-530. 10.1007/s00213-009-1561-0.
9. Coull J.T., Morgan H., Cambridge V.C., Moore J.W., Giorlando F., Adapa R., Corlett P.R., et al. Ketamine perturbs perception of the flow of time in healthy volunteers. Psychopharmacology 2011, 218(3):543-556. 10.1007/s00213-011-2346-9.
10. Desantis A., Roussel C., Waszak F. On the influence of causal beliefs on the feeling of agency. Consciousness and Cognition 2011, 20(4):1211-1220.
11. Dogge M., Schaap M., Custers R., Wegner D.M., Aarts H. Consciousness and Cognition 2012, 21(1):501-506.
12. Dickinson A. The 28th Bartlett memorial lecture. Causal learning: an associative analysis. The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology 2001, 54(1):3-25.
13. Elsner B., Hommel B. Contiguity and contingency in the acquisition of action effects. Psychological research 2004, 68:138-154.
14. Fletcher P.C., Honey G.D. Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends in Cognitive Sciences 2006, 10(4):167-174.
15. Fletcher Paul C, Frith C.D. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nature Reviews Neuroscience 2009, 10(1):48-58. 10.1038/nrn2536.
16. Frith C. The self in action: lessons from delusions of control. Consciousness and Cognition 2005, 14(4):752-770. 10.1016/j.concog.2005.04.002.
17. Frith C.D. The cognitive neuropsychology of schizophrenia 1992, Psychology Press.
18. Gallagher S. Philosophical conceptions of the self: implications for cognitive science. Trends in Cognitive Sciences 2000, 4(1):14-21.
19. Ghoneim M.M., Hinrichs J.V., Mewaldt S.P., Petersen R.C. Ketamine: behavioral effects of subanesthetic doses. Journal of Clinical Psychopharmacology 1985, 5(2):70-77.
20. Haggard P., Clark S., Kalogeras J. Voluntary action and conscious awareness. Nature Neuroscience 2002, 5(4):382-385. 10.1038/nn827.
21. Haggard P., Martin F., Taylor-Clarke M., Jeannerod M., Franck N. Awareness of action in schizophrenia. NeuroReport 2003, 14(7):1081-1085. 10.1097/01.wnr.0000073684.00308.c0.
22. Hauser M., Moore J.W., de Millas W., Gallinat J., Heinz A., Haggard P., Voss M. Sense of agency is altered in patients with a putative psychotic prodrome. Schizophrenia Research 2011, 126(1-3):20-27.
23. Honey R.A.E., Honey G.D., O'Loughlin C., Sharar S.R., Kumaran D., Bullmore E.T., Menon D.K., et al. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2004, 29(6):1203-1214. 10.1038/sj.npp.1300438.
24. Honey Rebekah A E, Turner D.C., Honey G.D., Sharar S.R., Kumaran D., Pomarol-Clotet E., McKenna P., et al. Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2003, 28(11):2037-2044. 10.1038/sj.npp.1300272.
25. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994, 51(3):199-214.
26. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2001, 25(4):455-467. 10.1016/S0893-133X(01)00243-3.
27. Mason O.J., Morgan C.J.M., Stefanovic A., Curran H.V. The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 2008, 103(1-3):138-142. 10.1016/j.schres.2008.02.020.
28. Meck W.H. Neuropharmacology of timing and time perception. Brain Research Cognitive Brain Research 1996, 3(3-4):227-242.
29. Moore J.W., Fletcher P.C. Sense of agency in health and disease: A review of cue integration approaches. Consciousness and Cognition 2012, 21(1):59-68. 10.1016/j.concog.2011.08.010.
30. Moore J., Haggard P. Awareness of action: Inference and prediction. Consciousness and Cognition 2008, 17(1):136-144.
31. Moore J.W., Haggard P. Intentional binding and higher order agency experience. Consciousness and Cognition 2010, 19(1):490-491.
32. Moore J.W., Lagnado D., Deal D.C., Haggard P. Feelings of control: contingency determines experience of action. Cognition 2009, 110(2):279-283.
33. Moore J.W., Obhi S.S. Intentional binding and the sense of agency: a review. Consciousness and Cognition 2012.
34. Moore James W, Lagnado D., Deal D.C., Haggard P. Feelings of control: contingency determines experience of action. Cognition 2009, 110(2):279-283. 10.1016/j.cognition.2008.11.006.
35. Moore James W, Schneider S.A., Schwingenschuh P., Moretto G., Bhatia K.P., Haggard P. Dopaminergic medication boosts action-effect binding in Parkinson's disease. Neuropsychologia 2010, 48(4):1125-1132. 10.1016/j.neuropsychologia.2009.12.014.
36. Moore James W, Wegner D.M., Haggard P. Modulating the sense of agency with external cues. Consciousness and Cognition 2009, 18(4):1056-1064. 10.1016/j.concog.2009.05.004.
37. Moore James W., Turner D.C., Corlett P.R., Arana F.S., Morgan H.L., Absalom A.R., Adapa R., et al. Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cognitive Neuropsychiatry 2011, 10.1080/13546805.2010.546074.
38. Morgan C.J.A., Mofeez A., Brandner B., Bromley L., Curran H.V. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2004, 29(1):208-218. 10.1038/sj.npp.1300342.
39. Murray G.K., Corlett P.R., Clark L., Pessiglione M., Blackwell A.D., Honey G., Jones P.B., et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry 2008, 13(3):267-276. 239. 10.1038/sj.mp.4002058.
40. Pomarol-Clotet E., Honey G.D., Murray G.K., Corlett P.R., Absalom A.R., Lee M., McKenna P.J., et al. Psychological effects of ketamine in healthy volunteers: phenomenological study. The British Journal of Psychiatry 2006, 189(2):173-179. 10.1192/bjp.bp.105.015263.
41. Rammsayer T. Temporal discrimination in schizophrenic and affective disorders: evidence for a dopamine-dependent internal clock. The International Journal of Neuroscience 1990, 53(2-4):111-120.
42. Schlagenhauf F., Sterzer P., Schmack K., Ballmaier M., Rapp M., Wrase J., Juckel G., et al. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biological Psychiatry 2009, 65(12):1032-1039. 10.1016/j.biopsych.2008.12.016.
43. Shergill S.S., Samson G., Bays P.M., Frith C.D., Wolpert D.M. Evidence for sensory prediction deficits in schizophrenia. The American Journal of Psychiatry 2005, 162(12):2384-2386. 10.1176/appi.ajp.162.12.2384.
44. Stetson C., Cui X., Montague P.R., Eagleman D.M. Motor-sensory recalibration leads to an illusory reversal of action and sensation. Neuron 2006, 51(5):651-659. 10.1016/j.neuron.2006.08.006.
45. Synofzik M., Thier P., Leube D.T., Schlotterbeck P., Lindner A. Misattributions of agency in schizophrenia are based on imprecise predictions about the sensory consequences of one's actions. Brain 2009.
46. Synofzik Matthis, Vosgerau G., Newen A. Beyond the comparator model: a multifactorial two-step account of agency. Consciousness and Cognition 2008, 17(1):219-239. 10.1016/j.concog.2007.03.010.
47. Tsakiris M., Prabhu G., Haggard P. Having a body versus moving your body: how agency structures body-ownership. Consciousness and Cognition 2006, 15(2):423-432. 10.1016/j.concog.2005.09.004.
48. Tsakiris M., Schütz-Bosbach S., Gallagher S. On agency and body-ownership: phenomenological and neurocognitive reflections. Consciousness and Cognition 2007, 16(3):645-660. 10.1016/j.concog.2007.05.012.
49. Voss M., Moore J., Hauser M., Gallinat J., Heinz A., Haggard P. Altered awareness of action in schizophrenia: a specific deficit in predicting action consequences. Brain: A Journal of Neurology 2010, 10.1093/brain/awq152.
50. Wegner D.M., Sparrow B. Authorship Processing 2004.
51. Wegner Daniel M, Sparrow B., Winerman L. Vicarious agency: experiencing control over the movements of others. Journal of Personality and Social Psychology 2004, 86(6):838-848. 10.1037/0022-3514.86.6.838.